Recognition and management of psychosis and schizophrenia in children and young people: Summary of NICE guidance

BMJ (Online)

Volumn 346, Issue 7892, 2013, Pages

  Kendall, Tim ^a,b,c   Hollis, Chris ^d   Stafford, Megan ^a   Taylor, Clare ^a  

^a ROYAL COLLEGE OF PSYCHIATRISTS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c SHEFFIELD HEALTH AND SOCIAL CARE NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; COGNITIVE THERAPY; DISEASE EXACERBATION; DRUG CHOICE; FAMILY THERAPY; HEALTH CARE DELIVERY; HOSPITAL CARE; HUMAN; MENTAL HEALTH SERVICE; PATIENT CARE; PATIENT EDUCATION; PATIENT MONITORING; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; RECURRENT DISEASE; SCHIZOPHRENIA; TREATMENT INDICATION;

ADOLESCENT; CHILD; HUMANS; PRACTICE GUIDELINES AS TOPIC; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84873039502     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f150     Document Type: Article

References (25)

1. Burd L, Kerbeshian J. A North Dakota prevalence study of schizophrenia presenting in childhood. J Am Acad Child Adolesc Psychiatry 1987;26:347-50.
2. Gillberg C. Epidemiology of early onset schizophrenia. In: Remschmidt H, ed. Schizophrenia in children and adolescents. Cambridge University Press, 2001:43-59.
3. Thomsen PH. Schizophrenia with childhood and adolescent onset-a nationwide register-based study. Acta Psychiatr Scand 1996;94:187-93.
4. World Health Organization. Division of Epidemiological Surveillance, Health Situation, and Trend Assessment. Global estimates for health situation assessment and projections 1990. World Health Organization, 1990.
5. Brown S, Kim M, Mitchell C, Inskip H. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 2010;196:116-21.
6. Ruhrmann S, Schultze-Lutter F, Salokangas RKR, Heinimaa M, Linszen D, Dingemans P, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the Prospective European Prediction of Psychosis Study. Arch Gen Psychiatry 2010;67:241-51.
7. NHS Confederation. Early intervention in psychosis services. Briefing 2011(219). www.iris-initiative.org.uk/silo/files/nhs-confederation-briefing-on- early-intervention-in-psychosis.pdf.
8. National Institute for Health and Clinical Excellence. Psychosis and schizophrenia in children and young people: recognition and management. (Clinical guideline 155.) 2013. http://guidance.nice.org.uk/CG155.
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition. (DSM-IV). American Psychiatric Association, 1994.
10. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization, 1992.
11. National Institute for Health and Clinical Excellence. Post-traumatic stress disorder (PTSD): the management of PTSD in adults and children in primary and secondary care. (Clinical guideline 26.) 2005. http://guidance.nice.org.uk/ CG26.
12. National Institute for Health and Clinical Excellence. Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder (Clinical guideline 31.) 2005. http://guidance.nice.org.uk/CG31.
13. National Institute for Health and Clinical Excellence. Depression in children and young people: identification and management in primary, community and secondary care. (Clinical guideline 28.) 2005http://guidance.nice.org.uk/ CG28.
14. National Institute for Health and Clinical Excellence. Borderline personality disorder: treatment and management. (Clinical guideline 78.) 2009. http://guidance.nice.org.uk/CG78.
15. National Institute for Health and Clinical Excellence. Antisocial personality disorder: treatment, management and prevention. (Clinical guideline 77.) 2009. http://guidance.nice.org.uk/CG77.
16. National Institute for Health and Clinical Excellence. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence. (Clinical guideline 115.) 2011. http://guidance.nice.org.uk/CG115.
17. National Institute for Health and Clinical Excellence. Alcohol-use disorders: preventing the development of hazardous and harmful drinking. (Public health guidance 24.) 2010. http://guidance.nice.org.uk/PH24.
18. National Institute for Health and Clinical Excellence. Alcohol-use disorders: diagnosis and clinical management of alcohol-related physical complications. (Clinical guideline 100.) 2010. http://guidance.nice.org.uk/ CG100.
19. National Institute for Health and Clinical Excellence. Drug misuse: psychosocial interventions. (Clinical guideline 51.) 2007. http://guidance.nice. org.uk/CG51.
20. National Institute for Health and Clinical Excellence. Drug misuse: opioid detoxification. (Clinical guideline 52.) 2009. http://guidance.nice.org. uk/CG52.
21. National Institute for Health and Clinical Excellence. Schizophrenia: core interventions in the treatment and management of schizophrenia in adults in primary and secondary care. (Clinical guideline 82.) 2009. http://guidance. nice.org.uk/CG82.
22. Pinfold V, Smith J, Shiers D. Audit of early intervention in psychosis service development in England 2005. Psychiatric Bulletin 2007;31:7-10.
23. Borneo A. Your choice: results from the your treatment, your choice survey 2008- final report. 2008. www.rethink.org/how-we-can-help/our-campaigns/ nice-schizophrenia-g.html.
24. Prescribing Observatory for Mental Health. Topic 10b Re-audit report: prescribing antipsychotics for children and adolescents. CCGI119 (data on file). London: Royal College of Psychiatrists, 2012.
25. De Hert M, Dobbelaere M, Sheridan EM, Cohen D, Correll CU. Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice. European Psychiatry 2011;26:144-58.